硬脂酸地塞米松硬膜外治疗大鼠腰椎管狭窄模型的疗效
本研究在大鼠腰椎管狭窄模型中比较硬膜外注射硬脂酸地塞米松(DEP)与地塞米松(DEX)的疗效。40只大鼠随机分组,观察21天机械痛阈和运动功能,并进行血液学与组织病理学检查。结果显示DEP在第三周仍持续缓解机械性痛觉超敏和运动功能障碍,且纤维化和染色质溶解较生理盐水组减轻,无激素过量或毒性表现。
要点
- 硬膜外DEP在大鼠腰椎管狭窄模型中可减轻慢性DRG压迫所致的痛觉超敏和痛觉过敏。
- DEP的镇痛效果在用药2周后显著,至第3周仍持续,而DEX效果开始减弱。
- DEP组纤维化和DRG染色质溶解较生理盐水组减少,未观察到激素过量或毒性。
核心结论
- 硬膜外注射DEP在大鼠腰椎管狭窄模型中可减轻慢性DRG压迫引起的痛觉超敏和痛觉过敏,提供更持久的疼痛缓解。
- DEP有望成为腰椎管狭窄相关疼痛的替代治疗选择。
研究设计与样本
- 40只大鼠随机分为四组:LSS模型接受硬膜外生理盐水(NS)、LSS模型接受硬膜外DEX、LSS模型接受硬膜外DEP、非模型大鼠接受硬膜外NS。
- 观察机械刺激缩足阈值和运动功能(神经源性间歇性跛行)长达21天,用药1周后进行血液学和血液生化分析,并采集组织进行类固醇病理检查。
主要发现
- DEX组和DEP组在药物治疗2周后机械性痛觉超敏和运动功能障碍均显著恢复(p<0.001)。
- 至第3周,DEX的效果开始减弱,而DEP的效果持续。
- DEP组较NS组纤维化减少、染色质溶解减轻。
- 各组均未观察到类固醇过量或毒性。
临床怎么用
- 对于腰椎管狭窄相关疼痛,硬膜外DEP可能提供比DEX更持久的镇痛效果,但需进一步临床验证。
- DEP可能减少局部纤维化和神经损伤,但当前证据仅来自大鼠模型,不能直接外推至临床剂量和方案。
局限性
- 本研究为动物实验,样本量有限,结果不能直接推广至人类。
- 未报告DEP的最佳剂量、注射体积及长期安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexamethasone palmitate (DEP), a prodrug of dexamethasone (DEX), is a synthetic corticosteroid medication distinguished by the inclusion of a fatty acid component known as palmitate. This study introduces DEP as a novel therapeutic option for spinal epidural injection, aiming to provide safer and longer-lasting pain relief as an alternative to for patients with spinal stenosis. METHODS: 40 rats were randomly divided into four groups: those receiving epidural administration of normal saline (NS), and DEP in the lumbar spinal stenosis (LSS) model, and non-model rats receiving epidural NS administration. Paw withdrawal thresholds to mechanical stimulation and motor function (neurogenic intermittent claudication) were observed for up to 21 days. Hematology and blood chemistry analyses were performed 1 week after drug therapy. Tissue samples were collected for steroid pathology examination to evaluate adhesion degree, perineural area inflammation, and chromatolysis in the dorsal root ganglion (DRG), and adrenal gland. RESULTS: The DEX and DEP groups demonstrated significant recovery from mechanical allodynia and motor dysfunction after 2 weeks of drug therapy (p<0.001). However, by the third week, the effect of DEX started to diminish while the effect of DEP persisted. Furthermore, the DEP group exhibited reduced fibrosis and less chromatolysis than the NS group. No steroid overdose or toxin was observed in any group. CONCLUSION: The epidural administration of DEP demonstrated therapeutic efficacy in reducing allodynia and hyperalgesia resulting from chronic DRG compression, thus offering prolonged pain relief. These findings underscore the potential of DEP as a promising treatment alternative for pain associated with LSS, serving as a viable substitute for .
引用
- Li MH, Zheng H, Choi EJ, et al. Therapeutic effect of epidural dexamethasone palmitate in a rat model of lumbar spinal stenosis. Reg Anesth Pain Med. 2025. PMID: 38960590. doi:10.1136/rapm-2024-105530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。